Hepatocellular carcinoma: Consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma Meeting

Abstract

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide and its incidence has rapidly increased in North America in recent years. Although there are many published guidelines to assist the clinician, there remain gaps in knowledge and areas of controversy surrounding the diagnosis and management of HCC. In February 2014, the Canadian Association for the Study of the Liver organized a one-day single-topic consensus conference on HCC. Herein, the authors present a summary of the topics covered and the result of voting on consensus statements presented at this meeting.

Figures

Figure 1)

Demographics of voters. GI Gastroenterology; HCC Hepatocellular carcinoma; yrs Years

Figure 2)

Algorithm for the diagnosis of hepatocellular carcinoma (HCC) after identification of a lesion on a surveillance ultrasound. CT Computed tomography; MRI Magnetic resonance imaging. Adapted with permission from reference

Figure 3)

Barcelona Clinic Liver Cancer stages and allocation of treatment. CP Child-Pugh class; LT Liver transplantation; PS Eastern Cooperative Oncology Group performance status; TACE Transarterial chemoembolization. Adapted with permission from reference